1. Home
  2. MAXN vs CELU Comparison

MAXN vs CELU Comparison

Compare MAXN & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maxeon Solar Technologies Ltd.

MAXN

Maxeon Solar Technologies Ltd.

HOLD

Current Price

$3.55

Market Cap

45.2M

Sector

Technology

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.60

Market Cap

50.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAXN
CELU
Founded
2019
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.2M
50.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MAXN
CELU
Price
$3.55
$1.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
72.1K
62.5K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$176,414,000.00
$40,578,000.00
Revenue This Year
$100.37
N/A
Revenue Next Year
$24.61
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.49
$1.00
52 Week High
$9.05
$4.35

Technical Indicators

Market Signals
Indicator
MAXN
CELU
Relative Strength Index (RSI) 62.84 33.82
Support Level $2.92 $1.62
Resistance Level $3.14 $2.01
Average True Range (ATR) 0.21 0.13
MACD 0.09 -0.02
Stochastic Oscillator 82.35 2.82

Price Performance

Historical Comparison
MAXN
CELU

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: